FRED AZAR 'Translational Multimodality Optical Imaging: applying state-of-the-art medical imaging technologies to bring optical imaging one step closer to the clinic'
Seminar, May 18th, 14.00. Seminar Room
FRED AZAR
Siemens Corporate Research Inc.
External Projects Lead, Imaging and Visualization
UNITED STATES
FRED AZAR
Siemens Corporate Research Inc.
External Projects Lead, Imaging and Visualization
UNITED STATES
As a full member of the Network for Translational Research in Optical Imaging (NTROI), Siemens Corporate Research (SCR) is responsible for bringing optical imaging technologies one step closer to the clinic by providing standardized post-processing techniques and enabling fusion and integration of optical imaging with the more established imaging techniques, such as Magnetic Resonance Imaging (MRI). During this presentation, we will mainly discuss two imaging systems developed specifically for the NTROI:
1. OMIRAD: The Optical and Multimodal Imaging Platform for Research, Assessment and Diagnosis. This platform enables multimodal integration, visualization and analysis of diffuse optical tomography (DOT) and magnetic resonance imaging (MRI) of breast cancer. The functional parameters, together with morphological parameters from MR can be suitably combined and correlated to the absolute diagnosis from histopathology. Fusion of the multimodal datasets may eventually lead to a significant improvement in the sensitivity and specificity of breast cancer detection. Fusion may also allow a priori structural information derived from MRI to be incorporated into the reconstruction of diffuse optical tomography images.
2. HANDHELD: A novel 3D visualization and guidance system for handheld optical imaging devices, and more specifically for Diffuse Optical Spectroscopy (DOS). The system provides a patient-centric approach, which enables more accurate longitudinal studies, 3D reconstruction of optical handheld measurements, joint analysis and fusion with other imaging modalities, and easier validation and translation into the clinic. The combined guidance system/DOS instrument becomes particularly useful for monitoring neoadjuvant chemotherapy in breast cancer patients and for longitudinal studies where measurement reproducibility is critical. A custom-built visualization and guidance system combined with a well-defined workflow provide the means for precise image-guided measurements, breast surface reconstruction, 3D reconstruction of optical properties, and serial data registration. We present experiments which confirm the stability and accuracy of the system as well as improvements which will enable translation of DOS technology into the clinical environment.
Seminar, 18th of May, 14:00h. Conference Room
Hosted by ICFO
1. OMIRAD: The Optical and Multimodal Imaging Platform for Research, Assessment and Diagnosis. This platform enables multimodal integration, visualization and analysis of diffuse optical tomography (DOT) and magnetic resonance imaging (MRI) of breast cancer. The functional parameters, together with morphological parameters from MR can be suitably combined and correlated to the absolute diagnosis from histopathology. Fusion of the multimodal datasets may eventually lead to a significant improvement in the sensitivity and specificity of breast cancer detection. Fusion may also allow a priori structural information derived from MRI to be incorporated into the reconstruction of diffuse optical tomography images.
2. HANDHELD: A novel 3D visualization and guidance system for handheld optical imaging devices, and more specifically for Diffuse Optical Spectroscopy (DOS). The system provides a patient-centric approach, which enables more accurate longitudinal studies, 3D reconstruction of optical handheld measurements, joint analysis and fusion with other imaging modalities, and easier validation and translation into the clinic. The combined guidance system/DOS instrument becomes particularly useful for monitoring neoadjuvant chemotherapy in breast cancer patients and for longitudinal studies where measurement reproducibility is critical. A custom-built visualization and guidance system combined with a well-defined workflow provide the means for precise image-guided measurements, breast surface reconstruction, 3D reconstruction of optical properties, and serial data registration. We present experiments which confirm the stability and accuracy of the system as well as improvements which will enable translation of DOS technology into the clinical environment.
Seminar, 18th of May, 14:00h. Conference Room
Hosted by ICFO
FRED AZAR 'Translational Multimodality Optical Imaging: applying state-of-the-art medical imaging technologies to bring optical imaging one step closer to the clinic'
Seminar, May 18th, 14.00. Seminar Room
FRED AZAR
Siemens Corporate Research Inc.
External Projects Lead, Imaging and Visualization
UNITED STATES
FRED AZAR
Siemens Corporate Research Inc.
External Projects Lead, Imaging and Visualization
UNITED STATES
As a full member of the Network for Translational Research in Optical Imaging (NTROI), Siemens Corporate Research (SCR) is responsible for bringing optical imaging technologies one step closer to the clinic by providing standardized post-processing techniques and enabling fusion and integration of optical imaging with the more established imaging techniques, such as Magnetic Resonance Imaging (MRI). During this presentation, we will mainly discuss two imaging systems developed specifically for the NTROI:
1. OMIRAD: The Optical and Multimodal Imaging Platform for Research, Assessment and Diagnosis. This platform enables multimodal integration, visualization and analysis of diffuse optical tomography (DOT) and magnetic resonance imaging (MRI) of breast cancer. The functional parameters, together with morphological parameters from MR can be suitably combined and correlated to the absolute diagnosis from histopathology. Fusion of the multimodal datasets may eventually lead to a significant improvement in the sensitivity and specificity of breast cancer detection. Fusion may also allow a priori structural information derived from MRI to be incorporated into the reconstruction of diffuse optical tomography images.
2. HANDHELD: A novel 3D visualization and guidance system for handheld optical imaging devices, and more specifically for Diffuse Optical Spectroscopy (DOS). The system provides a patient-centric approach, which enables more accurate longitudinal studies, 3D reconstruction of optical handheld measurements, joint analysis and fusion with other imaging modalities, and easier validation and translation into the clinic. The combined guidance system/DOS instrument becomes particularly useful for monitoring neoadjuvant chemotherapy in breast cancer patients and for longitudinal studies where measurement reproducibility is critical. A custom-built visualization and guidance system combined with a well-defined workflow provide the means for precise image-guided measurements, breast surface reconstruction, 3D reconstruction of optical properties, and serial data registration. We present experiments which confirm the stability and accuracy of the system as well as improvements which will enable translation of DOS technology into the clinical environment.
Seminar, 18th of May, 14:00h. Conference Room
Hosted by ICFO
1. OMIRAD: The Optical and Multimodal Imaging Platform for Research, Assessment and Diagnosis. This platform enables multimodal integration, visualization and analysis of diffuse optical tomography (DOT) and magnetic resonance imaging (MRI) of breast cancer. The functional parameters, together with morphological parameters from MR can be suitably combined and correlated to the absolute diagnosis from histopathology. Fusion of the multimodal datasets may eventually lead to a significant improvement in the sensitivity and specificity of breast cancer detection. Fusion may also allow a priori structural information derived from MRI to be incorporated into the reconstruction of diffuse optical tomography images.
2. HANDHELD: A novel 3D visualization and guidance system for handheld optical imaging devices, and more specifically for Diffuse Optical Spectroscopy (DOS). The system provides a patient-centric approach, which enables more accurate longitudinal studies, 3D reconstruction of optical handheld measurements, joint analysis and fusion with other imaging modalities, and easier validation and translation into the clinic. The combined guidance system/DOS instrument becomes particularly useful for monitoring neoadjuvant chemotherapy in breast cancer patients and for longitudinal studies where measurement reproducibility is critical. A custom-built visualization and guidance system combined with a well-defined workflow provide the means for precise image-guided measurements, breast surface reconstruction, 3D reconstruction of optical properties, and serial data registration. We present experiments which confirm the stability and accuracy of the system as well as improvements which will enable translation of DOS technology into the clinical environment.
Seminar, 18th of May, 14:00h. Conference Room
Hosted by ICFO